HCV NS3/4A Protease Inhibitors [MoA] class drugs

3 results

  • mavyret - glecaprevir and pibrentasvir tablet, film coated

    (Glecaprevir And Pibrentasvir)
    Abbvie Inc.
    Mavyret treats acute or chronic hepatitis C (genotypes 1–6) in adults and children 3+ without cirrhosis or with compensated cirrhosis. Also indicated for genotype 1 patients previously treated with an NS5A inhibitor or NS3/4A protease inhibitor (but not both).
    Medication Details
    Drug Interactions

  • vosevi - sofosbuvir, velpatasvir, and voxilaprevir tablet, film coated

    (Sofosbuvir, Velpatasvir, And Voxilaprevir)
    Gilead Sciences, Inc.
    Vosevi treats chronic hepatitis C (genotypes 1–6) in adults without cirrhosis or with compensated cirrhosis who were previously treated with an NS5A inhibitor, or genotype 1a/3 patients previously treated with sofosbuvir without an NS5A inhibitor.
    Medication Details
    Drug Interactions